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Abstract 
CRISPR/Cas9 can be used for precise genetic knock-in of epitope tags into 
endogenous genes, simplifying experimental analysis of protein function. However, 
Cas9-assisted epitope tagging in primary mammalian cell cultures is often inefficient 
and reliant on plasmid-based selection strategies. Here we demonstrate improved 
knock-in efficiencies of diverse tags (V5, 3XFLAG, Myc, HA) using co-delivery of Cas9 
protein pre-complexed with two-part synthetic modified RNAs (annealed 
crRNA:tracrRNA) and single-stranded oligodeoxynucleotide (ssODN) repair templates. 
Knock-in efficiencies of ~5-30%, were achieved without selection in embryonic stem 
(ES) cells, neural stem (NS) cells, and brain tumour-derived stem cells. Biallelic-
tagged clonal lines were readily derived and used to define Olig2 chromatin-bound 
interacting partners. Using our novel web-based design tool, we established a 96-well 
format pipeline that enabled V5-tagging of 60 different transcription factors. This 
efficient, selection-free and scalable epitope tagging pipeline enables systematic 
surveys of protein expression levels, subcellular localization, and interactors across 
diverse mammalian stem cells. 
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Introduction 
Defining the protein levels, subcellular localisation and biochemical interactions for 
the >20,000 protein-coding genes in the mammalian genome remains a formidable 
challenge. Ideally these would be explored across diverse primary cells – rather than 
genetically transformed and corrupted cell lines. Large-scale projects, such as the human 
protein atlas, have performed systematic characterisation of antibodies against native 
proteins (Thul et al. 2017). However, there are inherent difficulties in discovering, validating 
and distributing high-quality antibodies that cover all species and key applications (e.g. 
immunoblotting, immunoprecipitation, ChIP-Seq and immunocytochemistry).  
A complementary strategy is to use epitope tagging: the fusion of small peptide-
coding sequences to a protein of interest (e.g. 3XFLAG, HA, V5, and Myc) (Jarvik and 
Telmer 1998). In contrast to plasmid-driven cDNA overexpression, which creates artificially 
high protein levels, the knock-in of small epitope tags to endogenous genes provides 
physiologically relevant levels. A small set of pre-validated tag-specific antibodies is then 
used across diverse downstream experimental applications. This has been a key tool in 
yeast studies, resulting in global characterization of core protein complexes and their 
extensive interaction networks  (Gavin et al. 2006; Krogan et al. 2006). However, to date 
this approach has not been widely adopted in mammalian cells, primarily due to the poor 
efficiency of homologous recombination (HR). Repurposed programmable nucleases now 
provide a potential solution.  
Formation of a site-specific DNA double-strand break (DSBs), will massively 
enhance HR-mediated repair. This has become straightforward with the discovery and 
application of clustered regularly interspaced short palindromic repeats (CRISPR) and 
CRISPR-associated (Cas) proteins as designer site-specific nucleases. CRISPR/Cas9 was 
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uncovered as a form of microbial adaptive immunity (Bhaya et al. 2011) that has been 
repurposed for genome editing in mammalian cells (Cong et al. 2013; Doudna and 
Charpentier 2014).  
Cas9 is an RNA-guided endonuclease that binds complementary DNA via formation 
of a 20 bp RNA:DNA heteroduplex. Stable binding of Cas9/gRNA complex at the target site 
leads to activation of nuclease domains and formation of a double-stranded DNA break 
(DSB) (Jinek et al. 2014). DSBs are predominantly repaired through the error-prone non-
homologous end joining (NHEJ) pathway, resulting in insertion or deletion mutations 
(indels) (Sander and Joung 2014). Alternatively, at lower frequencies HR-mediated repair 
will occur. 
Successful knock-in of tags, therefore, requires co-delivery of three ingredients to the 
mammalian cells: the Cas9 protein, a guide RNA, and a donor repair template (i.e. single or 
double-stranded DNA encoding the tag or reporter with homology arms). These CRISPR 
components are typically delivered via transient plasmid transfection or viral vectors. 
Bespoke targeting vector plasmids are usually constructed for delivery of large cargoes or 
conditional alleles. Selection strategies, such as flow cytometry or use of antibiotic 
resistance cassettes, are then used to enrich for edited cells.  
Despite the successes of current approaches (Dalvai et al. 2015; Savic et al. 2015; 
Mikuni et al. 2016; Xiong et al. 2017), it is clear that many bottlenecks restrict widespread 
applications; i) Production of tailored plasmids for each component can be tedious and 
time-consuming; ii) Plasmid-based selection strategies introduce additional regulatory 
elements that can disrupt normal regulatory processes; iii) Plasmid DNA, either Cas9/gRNA 
expression vectors or targeting vectors, can randomly integrate in the genome causing 
insertional mutagenesis or increasing risks of off-target cleavage (Kim et al. 2014; Liang et 
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al. 2015); iv) current strategies are often not readily scalable to enable routine exploration of 
large numbers of genes; v) recovery of biallelic clonal lines is inefficient. Thus, there 
remains an unmet need for improved knock-in strategies that can work efficiently in primary 
mammalian cells, such as pluripotent (ES/iPS), multipotent (tissue stem cells) and cancer 
stem cells. 
Improved efficiencies of CRISPR editing in mammalian cells have been 
demonstrated using recombinant Cas9 protein (Kim et al. 2014; Ramakrishna et al. 2014; 
Bressan et al. 2017). Cas9 protein is complexed with in vitro-transcribed (IVT) RNA, to 
produce a ribonucleoprotein (RNP) complex that can be then delivered into cells. The RNPs 
are short-lived and cleared by cells within 24-48 hours, reducing the risk of both formation 
of mosaic clones or off-target cleavage (Kim et al. 2014; Lin et al. 2014; Zuris et al. 2015; 
Cameron et al. 2017). However, RNP-assisted methods have mainly been used for gene 
knock-out (Kim et al. 2014; Liang et al. 2015), incorporation of point mutations (Ma et al. 
2017; Rivera-Torres et al. 2017), or knock-in of restriction enzyme sites (Lin et al. 2014; 
Schumann et al. 2015). We and others have recently made use of RNP with in vitro-
transcribed (IVT) sgRNAs for CRIPSR epitope tagging (Bressan et al. 2017; Liang et al. 
2017), yet the efficiencies in the absence of selection are highly variable, and this approach 
cannot be scaled. 
To avoid IVT, chemically-modified ~100 nt-long sgRNAs can be synthesized (Hendel 
et al. 2015); however, these are prohibitively expensive, limiting applications. Alternatively, 
a two-part, chemically synthesized, short target-specific crRNA plus a longer generic 
tracrRNA can be used. This is cheaper (only the crRNA needs to be resynthesized for new 
targets) and has better performance  (Aida et al. 2015; Anderson et al. 2015). This ‘dual-
RNA’ approach has been advanced further by ‘base, backbone and end’ modifications of 
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cr/tracrRNAs (Rahdar et al. 2015; Kelley et al. 2016) and also by the use of shorter and 
more effective modified cr/tracrRNAs (Jacobi et al. 2017). Modified synthetic cr/tracrRNAs 
are resistant to nuclease digestion, limit cellular immune responses, have greater stability, 
and therefore provide enhanced targeting efficiency (Jacobi et al. 2017). 
Here we explored whether RNPs with synthetic modified two-part guide RNA can 
enhance efficiency of epitope tagging in mammalian stem cells. We find that co-delivery of 
a Cas9 RNP (dual-synthetic RNA) with ~200 bp single-stranded oligodeoxynucleotides 
(ssODNs) supports highly efficient epitope tagging. This is achieved across a variety of 
stem cell types without any requirement for plasmids, selection steps, flow cytometry-based 
enrichment, or IVT reactions. To provide a proof of principle, we developed a novel web-
based design tool and demonstrate effective tagging in 96-well plate format. We 
demonstrate one application, by identifying Olig2 protein partners using 
immunoprecipitation-mass spectrometry (IP-MS). 
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Results 
Cas9 protein complexed with synthetic cr/tracr RNAs enables highly efficient epitope 
tagging in neural and glioma stem cells 
sgRNAs produced by IVT reactions can vary in quality and quantity and are prone to 
degradation, either during production and/or following delivery into cells. We therefore 
explored a synthetic modified two-part guide RNA system (annealed 36-mer crRNA: 67-mer 
tracrRNA) (Anderson et al. 2015; Jacobi et al. 2017).  
 Guide RNAs were designed to cut proximal to the stop codon in the 3’ UTR of Olig2 
or Sox2 (Figure 1A). The efficacy of custom synthetic modified RNAs (csRNAs) was 
compared to IVT-generated sgRNAs. RNA was complexed with recombinant Cas9 protein 
and transfected into an adult mouse neural stem (NS) cell line (ANS4), using an optimised 
nucleofection program. RNP was delivered together with a ~200 bp single-stranded DNA 
donor encoding the V5 tag, flanked with ~70 nucleotide homology arms (Figure 1B). After 5 
days, cells were analysed using immunocytochemistry (ICC) for the V5 protein fusion 
(Figure 1C). The csRNA-based RNP (csRNP) gave a >4-fold and >10-fold increase in V5 
knock-in efficiency for Olig2 and Sox2, respectively (Figure 1D). Improved knock-in 
efficiencies were also obtained using an independent cell line (glioma-initiating neural stem 
cells; termed GNS) (Figure 1D). PCR genotyping and Sanger sequencing confirmed in-
frame and error-free insertion of V5 tag sequence at the C-terminus of Olig2 and Sox2 loci 
(Figure 1-figure supplement 1A). V5 positive cells all displayed the anticipated nuclear 
localization and levels with no indication of non-specific expression. 
Knock-in efficiency might vary when using distinct biochemical tags. We therefore 
tested a variety of widely used alternative tags (V5, HA, 3XFLAG, or Myc). Each tag varied 
substantially in size, and consequently homology arm length (Table 1). Nevertheless, we 
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observed similar rates of knock-in (15%-21%) across all four tags for Sox2 (Figure 1E; 
Table 1). An independent adult NS cell culture also gave similar results (9%-15% knock-in 
efficiency, Figure 1-figure supplement 1B).  
High knock-in efficiencies were not limited to Sox2 and Olig2. We found that Sox3, 
Sox8, and Sox9 – three Sox family members that are expressed in NS cells – had knock-in 
efficiencies of 30%, 14% and 26%, respectively (Figure 1F; Figure 1-figure supplement 
1C and Figure 1-figure supplement 2A). Furthermore, we could simultaneously knock-in 
two different tags (Sox2: HA tag; and Olig2: V5 tag) in the same cells using a single 
transfection (4% double-positive cells, Figure 1-figure supplement 2B). 
Altogether, these results indicate that use of the modified 2-part synthetic 
cr/tracrRNA system is more effective than IVT for epitope knock-in in mammalian NS and 
GNS cells. Using csRNP delivery, we achieved 5-30% knock-in efficiency across distinct 
cell lines for different genes and using different tags. Notably, this was accomplished 
without the requirement for flow cytometry or plasmid-based selection strategies. 
 
The high frequency of knock-in using csRNP facilitates simple recovery of biallelic-
tagged clonal lines 
Generation of biallelic-tagged clonal lines could be advantageous for downstream 
applications, as all target protein will be tagged, enabling improved signal to noise ratios in 
assays. Low efficiency of tagging requires screening of hundreds or thousands of clones 
that need to be screened and genotyped, limiting downstream applications. Heterozygous 
lines might also harbour indels on the other, non-HR tagged, allele (Merkle et al. 2015; 
Bressan et al. 2017), which may cause inappropriate transcriptional/post-transcriptional 
regulation. 
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The improved knock-in efficiency using the csRNP method encouraged us that 
recovery of biallelic clonal lines might be straightforward. Clonal NS cell lines were 
established from bulk tagged populations following single-cell deposition to 96-well plates. 
Tagged clones were then identified following replica plating and ICC for V5 tag (Figure 2A). 
Biallelic clones were scored using PCR primer-pairs flanking the tag sequence (Figure 2B) 
and validated using ICC and Sanger sequencing (Figure 2C; Figure 2-figure supplement 
1). 
89 clonal lines were generated from the Sox2-V5 knock-in cells. 13 of these were 
V5-positive by ICC and 11 were correctly targeted as confirmed by PCR (Table 2). Of these 
four had successfully integrated the V5 tag sequence at both alleles (30% of V5-positive 
clones) (Table 2). High frequencies of bi-allelic knock-in were also obtained for Sox3-V5 
(62.5%). We also derived several biallelic knock-in lines from another independent cell line 
(IENS, mouse GNS cells): Sox2, Sox3, Sox8 and Sox9 (7%, 26%, 57%, and 15% biallelic 
knock-in of V5-positive clones, respectively) (Table 2). Thus, biallelic-tagged clonal lines 
can be readily recovered. 
 
Multiple stem cell-types can be epitope-tagged using csRNPs, including non-
expressed genes 
To test the general applicability of the csRNP tagging method across other types of 
stem cells, we compared head-to-head tagging efficiencies between mouse ES cells and 
NS cells. We initially focussed on four transcription factors (TFs): Sox2, Sox3, Ctcf and 
Pou3f1, and the chromatin regulator Ezh2; each of these is expressed in both cell types. In 
each case we found that mouse ES cells (E14Tg2a) were tagged at similar level of 
efficiency to the NS cells (knock-in efficiency range 6% - 11%, Figure 3A,B). 
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Non-expressed genes are often difficult to engineer. We therefore tested csRNPs for 
several neural-affiliated TFs (Sox9, Pou3f2, and Pou3f3) that are expressed in NS cells but 
not ES cells (Figure 3C).  V5 insertion was first confirmed by PCR genotyping in the bulk 
populations and suggested both ES cells and NS cells were effectively tagged (Figure 3-
figure supplement 1). V5-tagged protein was detected by ICC only in NS cells and not in 
ES cells (Figure 3C, left and middle panels). However, for each of these genes, upon 
neural lineage differentiation of the ES cells, we noted a proportion of the Nestin-expressing 
neural rosettes that were V5-positive; 10.5%, 20%, and 11.8% for Sox9, Pou3f2, and 
Pou3f3, respectively (Figure 3C, right panel). Thus, non-expressed genes can be 
successfully tagged in ES cells, without deploying any selection strategies or plasmids. We 
also assessed csRNP-based tagging in human ES cells. V5 knock-in was successfully 
demonstrated in human ES cells for SOX2 (Figure 3D).  We also tested human GBM-
derived cells for OLIG2, SOX2, and SOX9 genes (15%-70% efficiency) (Figure 3D).  
These data illustrate the power of the csRNP-mediated efficient tagging of non-
expressed genes in stem cells, and subsequent monitoring of the tagged protein in their 
differentiating progeny. We also conclude that the same csRNP epitope tagging approach 
and reagents can work effectively across diverse mouse and human pluripotent stem cells, 
neural stem cells, and cancer-derived stem cells. 
 
DSB distance from the stop codon is a key parameter for successful tagging 
To further define the parameters influencing the reliability and efficiency of tagging, 
we attempted V5 epitope knock-in at the C-terminus for all 50 Sox and Fox genes. This set 
of genes included both expressed and non-expressed genes. Previous studies have 
indicated that the distance of the DSB to the insertion site influences the frequency of 
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successful HR (Bialk et al. 2015; Paquet et al. 2016; Liang et al. 2017). We designed two 
different target crRNAs in the 3’UTR of the gene for each of the 50 target genes; one 
cutting proximal and the other distal to the stop codon. For each of the TF, cells were 
transfected with Cas9 RNP containing either of the crRNA and a common matched ssODN 
to assess if distance of the cut site from the stop codon influenced knock-in efficiencies 
(Figure 4A).  
By PCR genotyping we found that both proximal and distal gRNAs could result in 
successful tagging in the majority of cases; 30/50 genes (60%) for proximal DSB and 27/50 
for the distal DSB (54%) (Figure 4-figure supplement 1,2,3). However, this assay is 
qualitative. To quantitatively score the knock-in efficiency, we performed V5 ICC assay for 
the seven expressed TFs (Figure 4B,C). Sanger sequencing confirmed targeted insertion 
of the V5 tag-coding sequence (Figure 4D). Importantly, by comparing the efficiency of 
tagging for these 7 genes, we noted a consistent trend towards increased tagging efficiency 
for the most proximal cut site. For example, Sox3 showed 18% and 5% knock-in efficiency, 
for proximal and distal gRNAs, respectively (Figure 4B). For four genes (Sox9, Foxj3, Fok1 
and Foxk2), the distal gRNA did not work, whereas the proximal gRNA facilitated high 
knock-in efficiency (Figure 4C). There were no genes for which the more distal gRNA 
worked better than the proximal gRNA. These results suggest proximity of DSB to the stop 
codon influences the efficiency of knock-in. 
 
A scalable pipeline for high-throughput knock-in of epitope tags using 96-well 
microplates 
It is often desirable to explore large numbers of proteins within a shared family, 
complex or pathway. Methods enabling knock-in of many genes in parallel would be 
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valuable. The gene-specific synthetic short crRNAs and matched ssODN repair templates 
can be obtained from commercial suppliers in 96-well microplates. Indeed, all steps can be 
performed easily in 96-well format: preparation of the transfection-ready components via 
automated liquid handling, benchtop incubation/annealing, 96-well transfection, and 
automated microscopy to acquire images across 96-well plates. We reasoned that scale-up 
could therefore be relatively straightforward. A major remaining bottleneck, however, is the 
need for bioinformatics design tools specifically tailored towards epitope tagging 
applications. 
Manually extracting gene sequence data, identifying appropriate gRNAs, and design 
of modified repair ssODNs, would be laborious and error-prone for hundreds of genes. To 
automate the batch design of crRNAs and ssODNs, we developed “Tag-IN”, a novel web-
based tool (Figure 5, http://tagin.stembio.org). This enables design of appropriate gRNA 
and ssODNs for both human and mouse species, with flexibility in choice of tag. Our ‘Tag-
IN’ incorporates key design rule and parameters – e.g. incorporating “Rule Set 2” for 
maximised activity (Doench et al. 2016), and “MIT” scoring model (Hsu et al. 2013) to 
minimize off-target effects. Our tool also considers optimal distance from the insertion site 
(stop codon), and outputs the matched ssODNs modified with PAM-blocking mutations and 
appropriate epitope tag sequence. ‘Tag-IN’ also enables batch design; critical for the 
effective scale up to 96-well format (Figure 5). 
 Using the Tag-IN tool, we designed crRNAs and matched V5 encoding repair 
ssODNs against 185 different transcription factors. Each of these crRNAs/ssODNs were 
also manually verified to ascertain that the tool picked proximal-cutting crRNA and the 
ssODNs contained appropriate PAM-blocking mutations and homology arms.  These 
mouse genes were selected based on expression in human glioblastoma stem cells.  One 
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gRNA was tested for each gene. The RNPs were prepared using a 96-well head liquid 
handling device (Felix, CyBio) and then transfected in parallel into mouse GNS cells 
(Figure 5). Five days later, ICC was performed and V5 knock-in efficiencies were quantified 
across the entire plate using automated plate image capture (Operetta high-content 
imaging system, Perkin Elmer). Sox2 tagging was used as a positive control in six wells; 
these gave consistent V5 knock-in efficiency across the plate, confirming no “edge-effects” 
during the procedure (10.5 ± 2.5%) (Figure 6A). 
Remarkably, for the first 96-well plate, 30 out of 90 TFs were positive for V5 ICC with 
typical knock-in efficiencies ranging from 6%-29% (Figure 6A,B). A second 96-well plate 
with distinct TFs showed similar knock-in efficiency (5%-38%), with 31 out of 95 TFs 
positive for V5 ICC (Figure 6C,D). These are similar efficiencies to those observed in our 
earlier single transfections (Figure 1,2). V5 ICC confirmed the expected nuclear localization 
of these TFs (Figure 6B). Thus, ~30% of genes were successfully tagged at the first 
attempt with good knock-in efficiency (Figure 6E).  
Interestingly, two of the V5 positive TFs- Cbfb and Ybx1, showed nucleocytoplasmic 
localization (Figure 6B,D). This illustrates the valuable information regarding protein 
localisation and levels data that can be quickly obtained. The frequency of successful 
genes tagged as scored by V5 ICC in these experiments is likely to be an underestimate, 
as ~20% of the failed TFs are low or non-expressed NS lines (Pollard lab, unpublished 
data). These results clearly demonstrate the ease with which our method can be scaled to 
96-well format epitope tagging. 
 
csRNP-derived knock-in lines can be used for immunoprecipitation-mass 
spectrometry (IP/MS) to identify protein partners 
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As a proof-of-principle of the applications, we performed V5-immunoprecipitation 
followed by mass spectrometry (IP-MS), to identify interaction partners of Olig2 in mouse 
GNS cells using the RIME (Mohammed et al. 2016) and ChIP-SICAP (Rafiee et al. 2016) 
methods. These enable identification of chromatin bound protein partners – the latter being 
more stringent for chromatin-bound proteins. For each assay, we used V5 monoclonal 
antibody conjugated to magnetic beads.  RIME analysis showed high enrichment of the bait 
protein Olig2 (Figure 7A) and subunits of SWI/SNF complexes and histone deacetylases 
(HDACs) in the pull-down complexes (Figure 7-source data 1). Physical interaction of 
Olig2 and SWI/SNF complex has been previously reported and this interaction is essential 
for oligodendrocyte differentiation (Yu et al. 2013). HDACs have a known functional role in 
Olig2 function during development.  
 
ChIP-SICAP analysis showed strong enrichment of Olig2 and core histone proteins 
suggesting specific pull-down of chromatin fragments bound by Olig2 TF (Figure 7B). 
Noteworthy, two other oligodendrocyte lineage transcription factors, Olig1 and Olig3, were 
detected among the most enriched proteins. Earlier studies reported that sets of genes 
regulated by various Olig proteins have a partial overlap (Ligon et al. 2007; Meijer et al. 
2012), explaining co-occupation of the same DNA-sites as shown by these data. 
Furthermore, we detected two other members of the basic helix-loop-helix (bHLH) family: 
Npas3 and Tcf4. The bHLH transcription factors are known to form heterodimers with other 
bHLH proteins on chromatin (Massari and Murre 2000) and the presence of Npas3 and 
Tcf4 may be explained by their direct physical interaction (Figure 7B; Figure 7-source 
data 1). Both Npas3 and Tcf4 have been reported to be involved in CNS development 
(Shin and Kim 2013; Chen et al. 2016). Interestingly, a recent study reporting interactions of 
Olig2, Tcf4 and Npas3 in mouse neural stem cells by FLAG-affinity purification (Moen et al. 
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2017) allowed us to correlate interactomes of all the three bHLH proteins with our data. 
Taken together, our results indicate that Tcf4 and Npas3 co-localize with Olig2 on 
chromatin, suggesting a functional interaction. 
In addition to protein interactions of Olig2 on-chromatin, we also analyzed the flow-
through of the streptavidin enrichment, representing interactions with soluble Olig2 
(Supplementary File 3). As expected, Olig2, Olig1, and Olig3 were found among the most 
highly abundant proteins, indicating high specificity of the immunoprecipitation. 
Furthermore, composition of identified proteins correlates with previous findings: we 
detected three known interactors of Olig2 (Cul3, Smarca4 and Sox8 (BioGRID, Intact)) and 
55 other proteins reported to co-precipitate with Olig2 (Moen et al. 2017) (Supplementary 
File 3). These included many SWI/SNF family members, and chromatin regulators Cbx3 
and Chd4, consistent with RIME. Collectively, our data confirm that V5-tagging can be 
effectively combined with ChIP-SICAP to identify proteins that co-localize on chromatin or 
that interact off-chromatin. 
 
Knock-in of mCherry fluorescent reporter in NS cells using dsDNA blocks and csRNP  
Insertion of fluorescent protein-encoding sequences (such as GFP, mCherry) in 
frame within gene coding regions enables monitoring of eukaryotic protein localization in 
live cells. Additionally, fusion proteins can be used for pull-down assays 
(immunoprecipitation and ChIP). Encouraged by the facile deployment and efficiencies of 
the Cas9 RNP method for small epitope tagging, we next asked if the same approach could 
be used for knock-in of relatively large mCherry-encoding DNA sequence (~700 bp) in NS 
cells. First, we tested the effect of variable length of homology arms on knock-in efficiency 
(Figure 8A). For these experiments, double-stranded linear DNA fragments harbouring 
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variable homology arms were used as donor DNA templates (PCR-amplified from a 
previously reported promoterless Sox2-mCherry plasmid) (Bressan et al.). We found that 
dsDNA with larger homology arms were more effective in mCherry knock-in (Figure 8B), 
although homology arms as small as 100 bp showed ~0.29% cells positive for mCherry in 
the bulk populations. We next tested mCherry knock-in at Olig2 and Foxg1 loci and 
achieved 0.34% and 0.11% efficiency, respectively (Figure 8C).  Live-imaging of mCherry-
sorted populations for the three genes (Sox2, Olig2, and Foxg1) showed the expected 
localisation and levels of fusion proteins in NS cells (Figure 8D). Together, these results 
show that our csRNP method can be used for knock-in of fluorescent reporters in NS cells. 
 
  
17 
Discussion  
An overarching goal in biology is to determine the key functions of each protein encoded 
in the genome. Epitope tagging of endogenous genes using CRISPR-assisted knock-in 
provides new opportunities to interrogate protein function, expression, subcellular 
localisation and interacting partners. In this study, we demonstrated simple and efficient 
epitope tag knock-in across a large number of genes in mouse and human stem cells.  
Use of Cas9 recombinant protein is critical. We found that when combined with synthetic 
modified RNAs significant enhancement in the efficiency is possible. This was achieved 
using inexpensive, faster and more reliable method – compared to plasmid-based 
strategies. Importantly, we showed primary mammalian stem cell lines are readily 
amenable to RNP engineering, without the need for plasmid production, or prior genetic 
manipulation of the host cell lines. Our method is therefore versatile enough to be 
implemented by any laboratory in their existing cell lines. All reagents can now be obtained 
‘off the shelf’. 
Assembly of RNPs with csRNAs is simple and requires only ~30 min hands-on-time; this 
compared favourably to IVT reactions, which require multiple steps, are time-consuming, 
and result in variable quality of gRNAs. In our hands, these reagents are stable at -20o C for 
many months, and is particularly convenient when re-used across a range of cell types. 
Perhaps more importantly, use of the custom synthetic cr/tracrRNAs with their modified 
backbone and protected ends, shields the RNA from cellular RNases. We found greatly 
reduced toxicity – one of the key advantages of the csRNP over IVT sgRNA and plasmids-
based delivery methods. 
 We routinely generated clonal knock-in lines in a time-frame of 4-6 weeks. 
Consistent with a previous report (Liang et al. 2015), we found that RNP complexes target 
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both copies of the genes at high frequency, enabling facile isolation of bi-allelic knock-in 
clones. Although monoallelic knock-in clones are sufficient for pull-down assays, bi-allelic 
clones are preferred to have more confidence in the interpretation of downstream assays.  
While our focus has been on neural stem cells and their malignant counterparts (glioma 
stem cells), these same methods and reagents can work well in other stem cells, such as 
ES cells. Indeed, our knock-in data using ES cells revealed that non-expressed genes can 
be efficiently tagged using the same protocol. Under appropriate differentiation cues, 
induction of these proteins can be monitored using ICC analysis in the ES cell 
differentiating progeny. We believe this could be a key application – rapidly enabling 
assessment of proteins across a range of lineage contexts. 
Despite the excitement, there are also some caveats. Foremost, inevitably there is a risk 
that C-terminus tagging can potentially compromise protein function, localisation or levels in 
the edited cells. Not all proteins will be amenable to tagging. If the protein of interest 
harbours critical C terminal domains, an N-terminus approach could be pursued – or knock-
in to other regions such as structurally neutral linkers, if this is known. In this study, we used 
PAM-strand (non-complementary strand) for donor DNA synthesis, which is less likely to be 
cut by Cas9 complex (Gasiunas et al. 2012). We have not compared PAM versus non-PAM 
donor DNA strands for knock-in efficiency although a recent report suggests that for 
symmetrical PAM ssODNs, both strands are equally effective for knock-in (Liang et al. 
2017).  
Previous findings have reported a higher HDR rate with the guide RNAs that cut near 
the insertion site (Bialk et al. 2015; Paquet et al. 2016; Liang et al. 2017). Our results 
corroborate these findings and reveal that cut-to-insertion-site distance is a critical factor for 
successful knock-in. Lower knock-in efficiency achieved with the distal-cutting gRNAs could 
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be attributed to “partial HDR” events (Guo et al. 2018), which are not detectable in our ICC 
end-point assays. Although beyond the scope of our present study, whole-genome 
sequencing of the CRISPR-edited bulk cells can shed light on the extent of “partial HDR” 
events in epitope knock-in experiments. The average size of CRISPR/Cas9-induced indels 
in mammalian cells has been reported to be around 1-5 bp (Paquet et al. 2016). We 
therefore recommend designing guide RNAs in the 3’UTR, preferably cutting 8-15 bp 
downstream of stop codon, to avoid interfering with the stop codon. 
The ability to scale-up tagging to 96-well format required us to tackle the bottleneck in 
design. Our newly developed ‘Tag-IN’ tool simplifies gene sequence retrieval and designing 
crRNA and ssODN for medium-throughput experiments and is available from any web 
browser (http://tagin.stembio.org). This can be modified for use with alternative design 
parameters and distinct tags. We demonstrated one of the key applications by single-cell 
imaging of the levels and localisation for 60 different transcription factors in glioma stem 
cells. These were successfully tagged without any screening of gRNAs or ssODN; those 
that failed could be due to the gRNA not working effectively or the ssODN donor being sub-
optimal. These could be re-tested with replacements – particularly for the ssODN, other tag 
can be used that works effectively in some instances (data not shown). Alternatively, the 
protein maybe expressed at levels too low to detect by ICC, but the tag insertion might still 
be detected by PCR genotyping. This is likely the case for 10-20% of the genes we 
explored. 
The pipeline that emerges is fully scalable and does not require sophisticated tools, 
expertise, or know-how. There are no significant bottlenecks in either the design, 
acquisition/production of reagents or delivery into cells. It was possible to generate such 
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data with relatively little labour investment, and the whole pipeline from obtaining the 
reagents to imaging data was accomplished within three weeks.   
Increasing the throughput further, we can envision systematic surveys of many 
hundreds or thousands of genes. Because tag-specific antibodies work universally across 
different cell types and species, this approach should allow cross-species comparisons and 
will also complement existing efforts to develop and characterise native antibodies. 
Furthermore, tagging of DNA-binding proteins will allow us to generate comprehensive 
genome-wide binding sites via ChIP-Seq for key transcription factors, chromatin-modifying 
enzymes, and other gene regulatory proteins. Although not a focus of the current study, we 
also find that csRNP is highly effective for gene knockout studies (Pollard laboratory, 
unpublished and (Jacobi et al. 2017). 
We demonstrated proof-of-principle in identification of Olig2 protein partners. This is 
likely a key application for future studies; simplifying and scaling up the ability to probe 
protein complexes in a range of cell types and cell states. Using the Olig2-V5 knockin lines 
we demonstrated on-chromatin partners in mouse glioma cells using optimised RIME and 
ChIP-SICAP methods, validating previously reported protein interaction partners. These 
optimised V5 RIME and ChIP-SICAP methods can now be deployed using the same 
optimised protocol for other mammalian proteins, particular for those with no good quality 
antibodies – a key advantage of epitope tagging.  
 With the remarkable developments in single-cell mRNA profiling, and plans for 
systematic RNA and protein atlases of mammalian cell types (Rozenblatt-Rosen et al. 
2017), there is a greater need than ever to relieve the bottleneck of exploring protein 
products. Descriptive maps of cell types, while valuable, must be complemented by careful 
and detail molecular and cellular functional studies. Our findings suggest that epitope using 
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CRISPR/Cas-assisted knock-in is now simple and efficient enough that systematic 
annotation of many hundreds or thousands of endogenous will be possible in mouse and 
human stem and progenitor cells. 
 
Appendix 1 
Detailed protocol for epitope knock-in using Cas9 RNP complex 
This protocol describes the step-by-step procedure for epitope tagging in neural stem (NS) 
cells. The same protocol can be used for other cell lines including ES cells. We used an 
Amaxa 4D Nucleofection system for the delivery of Cas9 RNP. The typical nucleofection 
reaction volume is 20 L (Lonza transfection buffer) plus 5 L (CRISPR/Cas9 reagents) in a 
16-well microcuvette. Calculations described below are for one nucleofection reaction and 
can be easily scaled up depending on the number of transfections. 
40-45 min before transfection: csRNP preparation 
1) In a sterile 0.2 mL PCR tube, mix 1.1 L of crRNA and 1.1 L of tracrRNA (each 
stock solution 100 M). Vortex and spin down. 
2) Anneal cr:tracrRNAs on PCR block using the following program: 
• 95 0C for 5 minutes 
• 95 0C – 25 0C: step cool-down at ramp-rate 0.1 0C/sec 
• 4 0C (store) at ramp rate 0.5 0C/sec 
Alternatively, heat the cr:tracrRNA mixture at 95 0C for five minutes and let it cool at 
room temperature for 30 minutes and plunge into ice. 
3) To the annealed cr:tracrRNAs, add 10 g of recombinant Cas9 protein (with NLS 
22 
and at 5-10 g/uL stock concentration). Ideally, the volume of these two components 
should be no more than 5-7 L. Incubate at room temperature for 10 min to allow 
Cas9 RNP formation and then plunge into ice until transfection.  
 
Just before transfection: Prepare cells for transfection 
Pre-warm 2 mL complete media supplemented with EGF/FGF/Laminin in a 6- or 12-well 
plate. Cells will be transferred into this immediately after transfection.  
4) Harvest cells using accutase dissociation. Count cells using trypan blue dye to 
ignore dead cells. Transfer 1.5 x 105 NS cells per transfection in a 15 mL tube and 
centrifuge cells at 1400 rpm for 3 minutes.  
5) Discard the supernatant and re-suspend the cells in 20 L of supplemented SG 
cell line buffer (SG cell line buffer should be brought to room temperature before 
use). Mix gently with pipette, avoid bubbles. Transfer to the 0.2 mL PCR tube that 
contains the Cas9 RNP.  
Note: Other cell types may require optimization of Lonza nucleofection buffer for 
high viability and transfection efficiency. 
6) Add 1 L of ssODN (30 M stock in IDT Duplex Buffer) to the cell suspension and 
Cas9 RNP mixture. Mix gently by pipetting, avoid bubbles. 
Electroporation: 
7) Set up the nucleofection program on 4D Amaxa machine to DN-100 for mouse NS 
cells.  
8) Carefully transfer cell suspension/Cas9 RNP mixture at the centre of a 
microcuvette well, avoid bubbles. We use two consecutive pulses of DN-100 
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program for mouse NS cells.  
9) Immediately after the nucleofection pulse(s), remove the microcuvette strip and 
add 150 L of pre-warmed supplemented media onto each microcuvette well. 
Transfer the cells into a pre-warmed 6 or 12-well plate containing 2 mL of 
supplemented media.  
10) Let the cells grow for 3-5 days, assay tag knock-in using ICC or PCR. 
 
Downstream assays: 
ICC: Seed 1 x 104 cells in a 96-well plate or 2 x104 cells in a 48-well plate for 
immunostaining. For the V5 tag detection, we use eBioscience anti-V5 tag antibody 
(1:1000) overnight at 4 0C. We prefer the far-red channel for secondary antibody (Alexa 
647), as it gives less background and is brighter as compared to the green channel. 
anti-V5 tag antibody: 
https://www.thermofisher.com/antibody/product/V5-Tag-Antibody-clone-TCM5-
Monoclonal/14-6796-80 
PCR: We use a nearly confluent 96- or 48-well plate for crude DNA extraction. Wash cells 
and add 50 L of lysis buffer + proteinase K directly into well; no accutase required. 
Incubate plate at 37 0C for 1 h, transfer the DNA extract into 0.2 ml PCR tubes and incubate 
at 50 0C for 2 h. Deactivate PK by heating at 95 0C for 10 min. Use 2 L of the final DNA 
extract as a template for 20 L LongAmp PCR reaction. Store DNA at -20 0C. To assess 
tag knock-in in the bulk populations, we use an exon-specific forward primer (400-500 bp 
upstream of the Stop codon) and a V5 tag-specific reverse primer. For the clonal lines, we 
use primers flanking the V5 tag such that the product size is ~400 bp in the parental cells 
and ~450 bp after the V5 knock-in.  
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LongAmp taq DNA polymerase: 
https://www.neb.com/products/m0323-longamp-taq-dna-polymerase 
PCR set up for 20 L reaction volume: 
• Sterile water -            10.8 L 
• 5x long amp buffer -    4.0 L  
• 10 mM dNTPs-            0.8 L 
• 10 M For primer-        0.8 L  
• 10 M Rev primer-       0.8 L 
• Taq polymerse-            0.8 L  
• Template-                     2.0 L (100 ng)  
 
PCR conditions: 
• 95 0C - 1 min  
• 94 0C for 30 sec  
• 60 0C - 30 sec            38 cycles             
• 65 0C - 45 sec (for 600 bp PCR product) 
• 65 0C - 10 min and store at 4 0C. 
Analyze PCR products on a 2.5% agarose gel, use 1kb+ gene ruler DNA ladder for 
size estimation. 
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Materials and Methods 
Key resources table 
Reagent 
type 
(species) 
or 
resource 
Designation Source or reference Identifiers Additional 
information 
gene 
(Homo 
sapiens) 
SOX2 NA Transcript ID_ENSEMBL: 
ENST00000325404 
 
gene 
(Homo 
sapiens) 
SOX9 NA Transcript ID_ENSEMBL: 
ENST00000245479 
 
gene 
(Homo 
sapiens) 
OLIG2 NA Transcript ID_ENSEMBL:  
ENST00000333337 
 
cell line 
(Mus 
musculus) 
ANS4 PMID: 28096221  mouse 
neural stem 
cells 
cell line 
(Mus 
musculus) 
BL6 PMID: 28096221  mouse 
neural stem 
cells 
cell line 
(Mus 
musculus) 
IENS PMID: 17936558   mouse 
glioma-
initiating 
stem cells 
cell line 
(Mus 
musculus) 
ES (Tg2a) This paper  mouse 
embryonic 
stem cells 
cell line 
(Homo 
sapiens) 
MasterShef7 
(MS7)  
This paper  human 
embryonic 
stem cells 
cell line 
(Homo 
sapiens) 
G7 human 
tumour-
derived 
This paper  Cell derived 
from GBM 
tumours 
antibody V5 tag eBioscience TCM5 #14-6796-82; 
RRID:AB_10718239 
1:1000 
Overnight 4 
degrees 
antibody HA Tag Cell Signalling 6E2 #2367; 
RRID:AB_10691311 
1:100 
Overnight 4 
degrees 
antibody FLAG tag Sigma-Aldrich  #F3165; RRID:AB_259529 1:2000 
Overnight 4 
degrees 
antibody Myc tag Cell Signalling 9B11 #2276; RRID:AB_331783 1:4000 
Overnight 4 
degrees 
antibody Alexa Fluor 
Plus 
Secondary 
antibody 
Thermo Fisher Scientific Alexa Fluor Plus 647; 
RRID:AB_141663 
1:1000 1 hr 
RT 
recombin
ant DNA 
reagent 
pET28a/Cas
9-Cys  
Addgene Addgene, #53261  
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peptide, 
recombin
ant 
protein 
Cas9 protein Addgene Addgene, #53261  
chemical 
compoun
d, drug 
crRNAs Integrated DNA Technologies, 
USA 
CRISPR-Cas9 crRNA  
chemical 
compoun
d, drug 
tracrRNAs Integrated DNA Technologies, 
USA 
CRISPR-Cas9 tracrRNA  
software, 
algorithm 
Tag-IN tool this paper http://tagin.stembio.org for crRNA 
ssODN 
design 
software, 
algorithm 
DESKGEN 
tool 
https://www.deskgen.com/landi
ng/cloud.html 
https://www.deskgen.com/landi
ng/cloud.html 
for crRNA 
ssODN 
design 
 
Cell culture 
Mouse and human NS and GNS cell lines were cultured essentially as described previously 
(Conti et al. 2005; Pollard et al. 2006). Laminin was purchased from Cultrex, R&D Systems. 
ANS4 and BL6 NS cell lines have been described previously (Bressan et al. 2017). Mouse 
ES (Tg2a) cells were cultured in GMEM supplemented with 10% fetal calf serum, 1x non-
essential amino acids,1x glutamine/sodium pyruvate, 1xLIF, 1x Pen/strep and 100 μM of  ß-
mercaptoethanol. Media was changed every day and cells passaged approximately every 
other day onto plates pre-coated with 0.1% gelatin. Differentiation of ES cell was performed 
as described previously (Pollard et al 2006) with 1x104 cells per cm2 being seeded in 
N2B27 complete media for 7 days, with media being changed every 1-2 days.  
MasterShef7 (MS7) human embryonic stem cells (hESCs) were re-cultured in 
Essential 8 (E8) medium (Gibco, A1517001) on tissue culture plastic coated with Human 
Recombinant Laminin-521 (BioLamina, LN521) at 5 μg/ml. Routine passaging was 
performed by incubating cells for 5 minutes at 37 °C in 0.5 mM EDTA in PBS. Single-cell 
dissociation prior to nucleofection was performed by incubating cells for 10 minutes at 37 
°C in accutase. Y-27632 (Cell Guidance Systems, SM02) was included in the culture 
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medium at 10 M following initial thawing and after plating following nucleofection. New 
engineered cell reporters described here are available upon request. No standard cell lines 
were used. We used primary stem cell lines. Human ES cells were provided by the UK 
stem cell bank and had appropriate contamination testing and authentication. 
 
Colony picking and clonal lines generation: 
Clonal cell lines were derived from the bulk populations using either single-cell 
deposition to 96-well plates or by manual colony picking. Single cells were deposited into 
96-well plates using BD FACSAria™ II cell sorter. Depending on the cell lines, we obtained 
30-40 colonies per 96-well plate in two weeks. For manual colony picking, mouse cells were 
seeded at clonal density (400 cells per 10 cm dish for NS cells, 100 cells per dish for GNS 
cells) to a 10cm dish and incubated in the complete media for 10-12 days for colony 
formation. From each dish, we picked 25-30 manually with a P20 pipette. Colonies from 
both methods were later replica plated into 96-well plates and analysed for successful 
knock-in using immunocytochemistry against the V5 tag. The V5 positive clones were 
further expanded for DNA extraction (PCR genotyping) and cryostorage. 
Design of guide RNAs and ssODN repair templates 
 For manual design: the 3’UTR sequence and 500 bp sequence upstream of the 3’UTR 
were retrieved using Biomart tool. The final coding exon and 3’UTR features were manually 
annotated using SnapGene and the ~200 bp around the stop codon were used as an input 
for guide RNA designing. We designed guide RNAs using either the web-based tool form 
Desktop Genetics (https://www.deskgen.com/landing/) or our own bioinformatics ‘Tag-IN’ 
tool (below). High scoring guide RNAs were picked for synthesis (i.e those with cut sites in 
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the 3’UTR, preferably within 8-15 bp distance from the stop codon and minimal predicted 
off-target cleavage). For ssODN design, first the PAM-blocking mutations (NGG>NGC or 
NGT) were introduced into the SnapGene sequence and then the epitope-tag coding 
sequence was inserted before the stop codon. The <200-mer ssODN ultramer was chosen 
to be the same strand as the guide RNA (also referred to as the PAM-strand, non-
complementary strand or non-targeting strand) and is comprised of: a 5’ homology arm 
(~70-mer), the epitope tag coding sequence, stop codon, and a 3’ homology arm with the 
PAM-blocking mutations (~70-mer). For some of the ultramers the PAM-strand synthesis 
had failed and, therefore, the complementary strand (non-PAM strand) was synthesized as 
a donor DNA. 
 
Custom synthetic crRNA, tracrRNA, and ssODN: 
Custom synthetic crRNAs, tracrRNA, and ssODNs were manufactured by Integrated DNA 
Technologies, USA. The RNA backbone and ends were chemically modified for protection 
against cellular RNases. The 36-mer crRNA contains a variable gene-specific 20-nt target 
sequence followed by 16-nt sequence that base-pairs with the tracrRNA. The 67-mer 
tracrRNA contains the gRNA-scaffold sequence as well as 16-nt sequence complementary 
to crRNA. The lyophilized crRNA and tracrRNA pellets were resuspended in Duplex buffer 
(IDT) at 100 M concentration and stored in small aliquots at -80 0C. ssODN donor DNAs 
lyophilized pellets were supplied without modifications and resuspended in Duplex buffer 
(IDT) at 30 M concentration. 
Production of in vitro-transcribed sgRNA 
DNA template for T7-driven synthesis was prepared by annealing 119-mer, single-stranded, 
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complementary ultramers (from IDT) encoding T7 promoter, guide RNA, and gRNA scaffold 
sequences. 200 ng of the template were used to synthesize sgRNA with the MEGAscript® 
T7 Transcription Kit. The sgRNA was further purified using MEGAclearTM Transcription 
Clean-Up Kit and stored at -80 0C. 
Production of recombinant Cas9 protein 
BL21(DE3) cells (New England Biolabs, C2527) were transformed with the plasmid 
pET28a/Cas9-Cys (Addgene, #53261) using standard protocols. Cas9 protein expression 
was induced with 0.5 mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) (Fisher, 10715114) 
and the cells were incubated overnight at 20 ºC. 24 h later, bacterial pellets were 
resuspended in 20 ml of lysis buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 1mM TCEP, 5 
mM imidazole pH 8.0), sonicated and loaded on a HisTrap HP 5 ml column (GE, 17-5248-
01). The Cas9 protein was collected in elution buffer (20 mM Tris-HCl pH 8.0, 250 mM 
NaCl, 10% glycerol, 1 mM TCEP, 250 mM imidazole pH 8.0). The fractions containing Cas9 
protein were pooled and loaded into a HiPrep 26/10 Desalting Column (GE, 28-4026-52) to 
equilibrate in Cas9 buffer (20 mM HEPES-KOH pH 7.5, 150 mM KCl, 1 mM TCEP). The 
purified Cas9 protein was further concentrated using Vivaspin columns (Vivaspin20, 30 000 
MWCO PES, Sartorius stedim, VS2021) as per the users-guide instructions.  
 
Assembly of the active ribonucleoprotein (Cas9 plus csRNAs) 
Synthetic Alt-R® CRISPR/Cas9 crRNAs and tracrRNA were supplied by IDT. We prepared 
Cas9 RNP complexes immediately before electroporation experiments (a detailed protocol 
in a separate Appendix 1 is available). Cas9 RNPs with IVT sgRNA were assembled (1-3 
g of IVT sgRNA with 5-10 g of Cas9 protein) as described previously (Bressan et al. 
2017) . For csRNP preparation, 100 picomoles of each crRNA and tracrRNA were annealed 
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using gradual step-down cooling in the PCR block (5 minutes at 95 0C, step cool-down from 
95 0C - 25 0C at ramp rate 0.1 0C/sec, 4 0C (store) at ramp rate 0.5 0C/sec). 
Ribonucleoprotein (RNP) complexes were assembled by adding 10 g of recombinant 
Cas9 protein to the annealed cr/tracrRNAs, incubated at room temperature for 10 minutes 
and stored on ice until electroporation into cells. 30 picomoles of single-stranded donor 
DNA were added to RNP complexes just before electroporation to prepare the complete 
RNP mix. For mCherry knock-in, csRNPs were prepared similarly and 200 ng of PCR 
products were used as donor DNA templates per reaction. For multiplex epitope tagging, 
100 picomoles of cr/tracrRNA of each Sox2 and Olig2 were mixed together with 20 g of 
rCas9 protein.  
Cell transfection 
 We used 4D Amaxa nucleofection system for the delivery of CRISPR ingredients. For NS 
cells and GNS cells, approximately 1.5 x 105 cells were resuspended in 20 L of Lonza SG 
cell line buffer and were mixed with the complete RNP mix and electroporated using the 
DN-100 program (two consecutive pulses for mouse NS cells) or using EN-138 program 
(one pulse for human GBM-derived cells). For embryonic stem cells, approximately 6 x 104 
cells in 20 L of Lonza P3 primary cell buffer were used for each transfection with different 
programs: one pulse of program CA-120 for mouse ESCs; program CB-150 for human 
ESCs. After the electroporation, cells were transferred into a 6-well plate and allowed to 
recover for 3-5 days and later seeded into 96-well plates (1-2 x 104 cells per well) for ICC. 
For scale up, RNP assembly and delivery were performed as above, except that 
RNP complexes were prepared a day before and stored at -20 0C. Electroporation was 
performed using the 96-well Shuttle® device (Amaxa, Lonza). Immediately after transfection 
cells were transferred into a 96 deep-well plate and replica plates for immunocytochemistry 
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assay were prepared by dispensing 1 x 104 cells into 96-well plate using CyBi®-FeliX Liquid 
Handling Platform. 
Immunocytochemistry and imaging: 
 We performed ICC on 96-well plates 5 days after transfection. Cells were washed once 
with PBS and fixed using 4% paraformaldehyde for 10 min at room temperature and then 
permeabilized in PBST (PBS + 0.1% Triton X-100) for 20 min. Samples were incubated 
with blocking solution (1% goat serum in PBST) for 30 min at room temperature to block 
non-specific binding of the antibodies. Samples were treated overnight with primary 
antibodies in blocking solution followed by incubation with appropriate secondary antibodies 
and 4′,6-diamidino-2-phenylindole (DAPI). Images were acquired using either a Nikon wide-
field fluorescence microscope or a PerkinElmer Operetta high-content imaging system. V5 
positive cells were scored using Fiji software. 
 The following primary antibodies were used: V5 tag (eBioscience, TCM5 #14-6796-
82,1:1000); HA Tag (Cell Signalling, 6E2 #2367, 1:100); FLAG tag (Sigma-Aldrich, #F3165, 
1:2000); Myc tag (Cell Signalling, 9B11 #2276, 1:4000), Alexa Fluor secondary antibodies 
mostly Alexa Fluor Plus 647 (Thermo Fisher Scientific, 1:1000). HCS CellMask™ Green 
Stain (Thermo Fisher Scientific, #H32714) for nucleocytoplasmic staining was used at 1: 
10,000 for 20 min at room temperature. 
Genomic DNA extraction and PCR genotyping: 
Genomic DNA was extracted either using in-house lysis buffer as described 
previously (Bressan et al. 2017) (bulk populations from 96-well plate or using DNeasy Blood 
& Tissue Kit (Qiagen, # 69506, for DNA extraction from clonal lines in a 24-well plate). PCR 
primers flanking the V5 tag were designed online using Primer3Plus to generate 400-600 
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bp PCR amplicons. PCR genotyping and Sanger sequencing were done as described 
previously (Bressan et al. 2017). DNA samples were analysed using 2.5% agarose gels. 
ChIP-SICAP and RIME 
Approximately 40 million mouse NS cells from three T150 flasks (150 cm2) were cultured 
until 70-80% confluence and then dissociated into single-cells using accutase. To fix DNA-
protein and protein-protein interactions, the cell pellet was resuspended in 1.5% methanol-
free formaldehyde (Pierce) in 10 mL PBS for 10 min at room temperature. Excess 
formaldehyde was quenched by adding 125 mM glycine and incubated for 5 min at room 
temperature. Cells were washed twice with cold PBS and stored at -80 °C until further use. 
ChIP-SICAP experiments were performed as described previously (Rafiee et al., 2016). 
Briefly, chromatin from 40 million formaldehyde-fixed cells was sheared by sonication 
(Bioruptor Pico, Diagenode) down to 150- 500 bp fragments, which were used as input for 
immunoprecipitation with anti V5 antibody (Abcam, 15828) overnight at 4° C. Antibody was 
captured with Protein-G beads (LIFE technologies, 10004D), the associated DNA was 
biotinylated by terminal deoxynucleotidyl transferase (Thermo Fisher, EP0162) in the 
presence of biotin-11-dCTP (Jena Bioscience, NU-809-BIOX). The antibody was eluted 
from the beads in 7.5% SDS with 200 mM DTT and the released DNA-protein complexes 
were caputred by streptavidin magnetic beads (NEB, S1420). After subsequent washes 
with SDS washing buffer (Tris-CL 1 mM, 1% SDS, 200 mM NaCl, 1 mM EDTA), 20% 
isopropanol and 40% acetonitrile, the beads were boiled in 0.1% SDS in 50 mM ammonium 
bicarbonate and 10 mM DTT at 95 °C for 20 min. Proteins were digested overnight with 
trypsin at 37 °C and the resulting peptides were purified with the SP3 protocol as described 
previously (Hughes et al. 2014) and analysed using an Orbitrap Fusion LC-MS system. 
crRNA/ssODN design tool 
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The implementation of our crRNA/ssODN design tool was completed in four stages: 
extraction of a target genomic sequence from GRCh38.p5 or GRCm38.p4 genome builds, 
retrieval of crRNA sequences matching the pattern N20NGG, scoring and ranking of each 
crRNA using the “Rule Set 2” (Doench et al. 2016) and “MIT” scoring models (Hsu et al. 
2013), and design of each corresponding ssODN sequence.  
To accommodate genomic sequence extraction, an SQL database of genomic coordinates 
was built using the Genomic Features package in R.  This SQL database was used to 
retrieve coding DNA sequence (CDS) ranges upon user query with a desired Ensembl 
transcript Id. Given a CDS range, a genomic sequence was then extracted from a 
corresponding GRCh38.p5 or GRCm38.p4 Fasta file.  
For each target genomic sequence, crRNAs were extracted limited to the pattern N20NGG. 
crRNAs were then ranked using two scoring models, “Rule Set 2” for assessing crRNA 
efficiency, and the MIT scoring system for crRNA specificity (Hsu et al. 2013; Doench et al. 
2016). The former was utilized as a standalone script retrieved from the “sgRNA Designer” 
website (https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design) and the 
latter was implemented as documented on the “CRISPR Design” website 
(http://crispr.mit.edu/about). Off targets for each crRNA were found using the short read 
aligner tool Bowtie, searching up to 3 mismatches (Langmead et al. 2009). Off targets that 
then match the PAM pattern NAG and NGG were extracted from the Bowtie output.  In 
addition, crRNAs that cut close to the stop codon (8-15 bp in the 3’UTR), and within the 
UTR region, were prioritized. Given a batch request, the top two ranking crRNAs were 
selected for output. A maximum distance of 30 bp from the stop codon was chosen as an 
additional threshold for batch processing.  
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To implement ssODN design, user-defined tags were inserted immediately 5I proximal to 
the stop codon.  PAM sequences were changed to minimise potential for Cas9 cleavage of 
donor sequences. Where the PAM sequence resided in the 3I UTR, our tool modified the 
NGG PAM to NGC. Intronic or exonic PAM changes instead aimed to produce silent 
mutations, and where this was not possible, aimed to reduce alterations in function by 
minimising differences in hydrophobicity and charge. Final ssODN sequences were limited 
to 200-mer including the tag sequence. We therefore present the “Tag-IN” design tool, a 
novel crRNA and ssODN design tool aimed at streamlining CRISPR knock-in 
experimentation (http://tagin.stembio.org). 
Immunoprecipitation-mass spectrometry 
 
The Olig2 protein interactors were identified using the Rapid immunoprecipitation 
mass spectrometry of endogenous protein (RIME) protocol. The nuclear fraction was 
resuspended using 1 ml of LB1 (50 mM HEPES KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 
10% glycerol,  and 0.5% NP-40) with protease and phosphatase inhibitors. Lysate was 
cleared by centrifugation at 2000g for 5 min at 4 °C and the pellet was resuspended with 1 
ml of LB2 (10 mM Tris-HCL [pH 8.0], 200 mM NaCl, 1 mM EDTA, and 0.5 mM EGTA), and 
mixed at 4 °C for 5 min. Lysate was cleared by centrifugation and the pellet was 
resuspended in 0.5 ml of LB3 (10 mM Tris-HCl [pH 8], 100 mM NaCl, 1 mM EDTA, 0.5 mM 
EGTA, 0.1% Na-deoxycholate, and 0.5% N-lauroylsarcosine). Samples were sonicated in a 
waterbath sonicator (Diagenode Bioruptor) and cleared by centrifugation. 10 µL V5 trap 
magnetic beads (MBL) were used per sample. IPs, washes and on-bead digests were 
performed using a Thermo Kingfisher Duo, all steps are at 5 °C unless otherwise 
stated.  Beads were transferred into 500 L of cleared lysate and incubated for 2 hours with 
mixing.  Beads were then transferred for two washes in RIPA buffer and three washes in 
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non-detergent lysis buffer. On-bead digest was performed by transferring the washed 
beads into 100 L 2M urea, 100 mM Tris-HCl pH 7.5, 1 mM DTT containing 0.3 g  trypsin 
(Promega) per sample, beads were incubated at 27 °C for 30 minutes with mixing to 
achieve limited proteolysis. The beads were then removed and tryptic digest of the released 
peptides was allowed to continue for 9 hours at 37 °C. Reduced cysteine residues were 
alkylated by adding iodoacetamide solution to a final concentration of 50 mM and incubated 
30 min at room temperature, in the dark. Trypsin activity was inhibited by acidification of 
samples to a concentration of 1% TFA. Samples were desalted on a C18 Stage tip and 
eluates were analysed by HPLC coupled to a Q-Exactive mass spectrometer as described 
previously (Turriziani et al. 2014). Peptides and proteins were identified and quantified with 
the MaxQuant software package (1.5.3.8), and label-free quantification was performed by 
MaxLFQ (Cox et al. 2014). The search included variable modifications for oxidation of 
methionine, protein N-terminal acetylation, and carbamidomethylation as fixed modification. 
The FDR, determined by searching a reverse database, was set at 0.01 for both peptides 
and proteins. 
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Figure 1 | Cas9 protein in complex with synthetic cr/tracrRNAs enables highly 
efficient knock-in of biochemical tags in mouse neural and glioma stem cells. 
(A) Schematic representation of epitope knock-in strategy. A crRNA was designed against 
the 3’UTR of each target gene. Target site with double-stranded break is shown with Cas9 
RNP (grey), PAM in yellow box, and single-stranded donor DNA that harbours PAM-
blocking mutations and V5 tag coding sequence flanked by 70-mer homology arms on both 
sides. (B) Cas9 RNP complexes were assembled in vitro by incubation of recombinant 
Cas9 protein with either IVT sgRNA or synthetic two-part cr:tracrRNA and electroporated 
into NS cells. V5 ICC was used to quantify knock-in. (C) Representative ICC images for the 
detection of Olig2-V5 fusion protein in the bulk populations of transfected cells. (D) HDR-
mediated insertion of V5 tag was determined by scoring V5-positive cells (%) in the bulk 
populations of transfected cells. Results from three independent experiments are shown for 
Sox2 and Olig2 V5 tagging using mouse neural stem (NS) and glioma-initiating neural stem 
(GNS) cells. Error bars indicate standard deviation values based on a minimum of two 
experiments, P-values were derived using unpaired t test. (E) ICC for Sox2 gene epitope 
tagging at the C-terminus with V5, HA, 3XFLAG, or Myc epitope. Numbers represent 
percentage of tagged cells in the bulk population for each tagging experiment. (F) 
Representative bulk population V5 ICC images for Sox2, Sox3, Sox8, and Sox9 V5 knock-
in are shown. Average knock-in efficiency from two independent experiments is shown at 
the bottom (numbers in white). 
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 Figure 2 | Bi-allelic knock-in clonal lines can be readily generated.   
(A) Experimental workflow for generating clonal lines. Cells from the bulk population 
cultures were single-cell deposited to 96-well plates using flow cytometry. Two weeks later, 
V5 positive clones were selected by ICC assay and confirmed by PCR genotyping. (B) 
Representative agarose gel pictures for Sox2-V5 and Sox3-V5 PCR genotyping are shown. 
Wild-type unedited cells (control) are marked with WT; 1kb+ DNA ladder is marked with L; 
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bi-allelic clones are marked with red asterisks. (C) ICC images of bi-allelic V5 knock-in 
clones are shown for Sox2 and Sox3 TFs. Nuclear stain DAPI (blue), entire cell stain 
CellMaskTM HCS (green), and V5 tag (yellow) are shown.  
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Figure 3 | Variety of cell types can be epitope-tagged using RNP method. 
Representative V5 ICC images are shown for V5 tagging of five TFs that are expressed in 
both mouse NS cells (A) and ES cells (B). V5 ICC images for the three neural-specific TFs 
Sox9, Pou3f2, and Pou3f3 in mouse NS cells (Figure C, left panel). Mouse ES cells were 
electroporated with similar three TF-reagents (Figure C, middle panel). Later, ES bulk 
populations of non-expressed TFs were differentiated into neural lineage and assayed for 
expression of TF-V5 fusion proteins by ICC (Figure C, right panel). Differentiation into 
neural stem progenitors was confirmed by Nestin ICC (in green), only V5-positive rossettes 
for each of the three genes are shown. (D) V5 ICC images for epitope tagging using human 
ES cells and GBM patient-derived cell lines. 
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Figure 4 | csRNP cutting proximal to insertion site is more efficient and allows knock-
in at non-expressed genes. 
(A) Schematic showing the relative position of guide RNAs in the 3’ UTR. The first set of 
gRNA (gRNA1) cuts proximal to the stop codon, the second set gRNA 2 distal. Average 
distance of cut site from the insertion site is shown for both sets of gRNAs against 50 TFs. 
(B) Representative V5 ICC images of Sox3, Sox5, and Sox8 V5 knock-in bulk populations 
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obtained with gRNA 1 (left panels) and gRNA 2 (right panels) are shown; % V5 knock-in 
efficiency for each experiment is shown at the right bottom of V5 panels (numbers in white). 
(C) Heatmap representation of V5 knock-in efficiency obtained with gRNA1 and gRNA2 for 
different genes, color code is shown on the right. (D) Example of sequencing traces using 
the bulk populations of V5-tagged cells for Sox8 and Foxj3. Alignment with the expected 
TF-V5 chimeric sequence is shown.  
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Figure 5 | A simple pipeline for high-throughput epitope knock-in using 96-well 
format. In the first step, crRNAs and matched ssODNs are designed (either single input or 
batch processing) using the ‘Tag-IN’ bioinformatics tool. The tool picks top two crRNAs in 
the 3’UTR (within 8-15 bp from stop codon if high-quality crRNAs available) and designs an 
ssODN for each query based on user’s choice of the epitope tag. After the procurement of 
CRISPR ingredients from the supplier, the RNPs and matched ssODNs are assembled in 
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vitro in 96-well plates (step 2) and transfected into stem cells using Amaxa shuttle system 
(step 3). Five days after the transfection, a replica plate is processed for V5 ICC and 
images are captured using high-content imaging system Operetta (step 4). V5-positive cells 
from the corresponding wells can be later expanded to derive clonal lines for downstream 
applications (step 5,6). 
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Figure 6 | High-throughput epitope knock-in in a 96-well format. 
(A) Heat map of V5 knock-in efficiency across the entire 96-well plate. The positive control 
Sox2 was included in 6 different wells (marked with ‘+’). (B) Representative ICC images of 
V5 knock-in from figure (a) are shown, nuclear stain DAPI (blue) and TF-V5 fusion protein 
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(yellow) are shown. (C) A 96-well plate heatmap of V5 knock-in for another set of 96 TFs. 
(D) Representative V5 knock-in panels, as obtained from the Operetta system, for the 96-
well plate from (C) are shown, well number is indicated in the merged panel of each TF. 
Nuclear stain DAPI (blue), entire cell stain CellMaskTM HCS (green), and V5 tag (red) are 
shown. (E) Top 30 TFs with highest knock-in efficiency from (A) and (C). 
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Figure 7 | Identification of Olig2 partners using V5 knock-in lines. 
Mouse GNS Olig2-V5 cells were used for the identification of Olig2 interaction partners. (A) 
RIME analysis, volcano plot showing log(2) fold change plotted against −log(10) p value for 
endogenously V5-tagged Olig2 samples versus samples generated from an untagged 
parental cell line. (B) ChIP-SICAP analysis, proteins identified in the chromatin-bound 
complexes are ranked based on iBAQ score in the descending order.  
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Figure 8: Knock-in of mCherry reporter using Cas9 RNP delivery. (A) Schematics of 
the mCherry knock-in experiment is shown. NS cells were electroplated with Cas9 RNP 
complex along with a dsDNA donor DNA, which was amplified using a vector plasmid that 
harbours mCherry encoding sequences flanked by promoter-less Sox2 homology arms. 
Cells were allowed to recover and expand for 7 days and then analysed by flow-cytometry 
for mCherry knock-in. (B) Flow-cytometry analysis of mCherry knock-in at Sox2 locus. 
Effect of variable length of homology arms was assessed, composite graph for all the 
panels is shown at the right bottom. (C) Flow-cytometry analysis of mCherry knock-in at 
Olig2 and Foxg1 loci, a donor DNA containing 500 bp homology arms was used for each 
gene. (D) Live-images of the mCherry-sorted populations are shown. Top panels show 
phase contrast and mCherry merged; bottom panels show mCherry alone. 
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Legends for supplement figures 
Figure 1-figure supplement 1: PCR genotyping and Sanger sequencing of V5 knock-in 
bulk populations show error-free insertion of the tag-encoding sequence. Schematic of 
genotyping strategy. Agarose gel on the right. Gene name and guide RNA source (IVT or 
synthetic 2-part gRNA) are indicated on the top of each lane in the gel. (A) Sequencing 
traces from the respective PCR amplicons were aligned with the expected TF-V5 chimeric 
sequence, Olig2-V5 and Sox2-V5 are shown.  (B) Sox2 gene tagged independently with 
four different epitope tags in mouse NS BL6 cells, bulk population ICC images for each 
epitope tag are shown. (C) Mouse BL6 were transfected with RNPs and V5-encoding 
ultramers for V5 epitope tagging of indicated genes. Representative bulk population V5 ICC 
images for each TF are shown.  
Figure 1-figure supplement 2: PCR genotyping and Sanger sequencing of V5 knock-in 
bulk populations show error-free insertion of the tag-encoding sequence. (A) synthetic 2-
part gRNA system was used to knock-in V5 tag at the indicated genes in mouse NS cells. 
Sequence alignment of Sox3-V5, Sox8-V5, and Sox9-V5 sequencing traces with the 
expected sequences are shown. (B) GNS cells were nucleofected with Sox2-HA and Olig2-
V5 ssODNs in a combined reaction (dual-epitope tagging). Transfected cells were analyzed 
for V5 and HA knock-in by ICC; 4% cells were positive for both the tags (marked with 
arrows in the first panel).  
Figure 2-figure supplement 1: Sanger sequencing of V5 knock-in clonal lines. (A) 
Schematics shows the PCR amplification of HDR-edited loci using a primer pair flanking the 
V5 tag sequence. (B) Sequencing traces for the V5 clonal knock-in lines were aligned with 
the expected TF-V5 chimeric sequence; Sox2 and Sox3 V5 traces for BL6 clonal lines are 
shown. Red asterisks denote stop codon, the crRNA is highlighted in green, PAM with 
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blocking mutations in yellow, the cut-site is marked with a double-headed arrow in red. (C) 
Sequencing trace alignment for V5 knock-in using mouse GNS clonal lines (IENS); Sox2, 
Sox8, and Sox9 V5 knock-in sequencing traces are shown. 
Figure 3-figure supplement 1: PCR genotyping and sequence confirmation of V5 tagging 
in mouse ES cells. (A) PCR strategy is shown, a V5 tag-specific reverse primer and a TF 
exon-specific forward primer were used to amplify HDR-edited alleles using bulk population 
of ES cells. (B) Agarose gel analysis of PCR products, gene names are indicated at the top 
of each lane, ‘-‘ refers to control unedited cells, ‘+’ refers to edited cells, 1kb+ DNA ladder is 
marked with ‘L’. (C)  Sequencing trace alignments for some of the edited genes from (b) are 
shown, Ctcf and Ezh2 genes are expressed in ES cells, Sox9 is expressed after 
differentiation of ES cells into neuronal lineage. 
Figure 4-figure supplement 1: V5 tag-specific PCR amplification of bulk populations gene-
edited using first set of gRNAs. (A) Schematics showing location of gRNAs, first set of 
gRNAs cut proximal to the stop codon and shown in red. (B) PCR strategy is shown, a V5 
tag-specific reverse primer and a TF exon-specific forward primer were used to amplify 
HDR-edited regions for each of the 50 TFs. (C) Agarose gel analysis of PCR product. Gene 
names are indicated at the top of each lane, lanes marked with ‘+’ denote successful 
knock-in of the V5-encoding sequence at the target gene (based on the expected size of 
PCR products), 1kb+ DNA ladder is marked ‘L’. 
Figure 4-figure supplement 2: V5 tag-specific PCR amplification of bulk populations gene-
edited using second set of gRNAs. (A) Schematics showing location of gRNAs, second set 
of gRNAs cut distal to the stop codon and shown in red. (B) PCR strategy is shown, a V5 
tag-specific reverse primer and a TF exon-specific forward primer were used to amplify 
HDR-edited regions for each of the 50 TFs. (C) Agarose gel analysis of PCR product. Gene 
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names are indicated at the top of each lane, lanes marked with ‘+’ denote successful 
knock-in of the V5-encoding sequence at the target gene (based on the expected size of 
PCR products), 1kb+ DNA ladder is marked ‘L’. 
Figure 4-figure supplement 3: Sanger sequencing confirms error-free insertion of V5-
encoding sequence at the C-terminus of expressed and non-expressed genes. Schematics 
at the top shows the PCR amplification of HDR-edited loci using a TF exon-specific forward 
primer and a V5 tag-specific reverse primer. Sequencing traces from the respective PCR 
amplicons were aligned with the expected TF-V5 chimeric sequence.  
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Mouse NS cells (ANS4)   
Tag Tag size (bp) Homology Arms (bp) Knock-in efficiency (%) 
3XFLAG 66 67 21.2 
V5 42 79 17.6 
Myc 30 85 14.9 
HA 27 86 15.8 
    
    
Mouse NS cells (BL6)   
Tag Tag size (bp) Homology Arms (bp) Knock-in efficiency (%) 
3XFLAG 66 67 13.7 
V5 42 79 13.9 
Myc 30 85 9 
HA 27 86 14.6 
 
Table 1: Larger cargos (3XFLAG) could be inserted with high knock-in frequency at 
mouse Sox2 locus. 
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Cell type Gene Colonies 
picked 
V5 positive 
(ICC) 
Correctly targeted 
(PCR) 
Bi-allelic 
(PCR) 
Mouse NS 
cells 
Sox2 89 13 11 4 
 Sox3 55 8 6 5 
Mouse GBM-
model  
cells 
Sox2 242 14 14 1 
 Sox3 96 19 18 5 
 Sox8 96 7 6 4 
 Sox9 469 46 41 7 
 Foxk2 96 2 2 1 
 
Table 2: Summary of knock-in lines generated using csRNP delivery.  
Table summarizing knock-in lines derived from mouse NS and GBM-model cells. The % bi-
allelic knock-in among all V5 positive clones, as confirmed by PCR genotyping, is listed in 
the last column. 
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Source data and other supplementary files 
 
Figure 1-source data 1.xlsx | Raw data for IVT sgRNA versus 2-part cr:tracrRNA-based 
V5 knock-in efficiency in NS and GNS cells. 
Figure 4-source data 1.xlsx | Raw data for V5 knock-in efficiency using two sets of guide 
RNAs. 
Figure 6-source data 1.xlsx | Raw data for V5 knock-in efficiency across the 96-well plate. 
Figure 7-source data 1.xlsx | Raw data for Olig2 interaction partners obtained from RIME 
and ChIP-SICAP analyses. 
Figure 8-source data 1.xlsx | Raw data for Sox2-mCherry knock-in efficiency using 
variable lengths of homology arms. 
Table 1-source data 1.xlsx | Raw data for epitope tag knock-in efficiency using 3XFLAG, 
HA, V5, and Myc single-stranded donor DNA templates. 
Table 2-source data 1.xlsx | Raw data for V5 ICC and PCR genotyping of clonal knock-in 
lines. 
Supplementary File 1 | List of crRNA targets and ssODN sequences 
 
 
Supplementary File 2 | List of primers for PCR genotyping 
 
 
Supplementary File 3 | Protein interaction partners of Olig2 identified by ChIP-SICAP 
soluble fraction 
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